Case report: Safety and efficacy of adalimumab in treating difficult-to-treat rheumatoid arthritis in a human immunodeficiency virus-positive patient, one year follow-up

Rheumatoid arthritis (RA) is a joint-disabling inflammatory disease associated with the pathology of synovitis. Some patients with RA are difficult to treat, using disease-modifying anti-rheumatic drugs (DMARDs). Biology and targeted synthetic DMARDs (b/tsDMARDs) are options for patients with RA. Ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jing-Wen, Deng, Guo-Shu, Zhang, Wen-Shuang, Zhang, Ming-Ying, Guan, Tong, Xu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382239/
https://www.ncbi.nlm.nih.gov/pubmed/35990692
http://dx.doi.org/10.3389/fimmu.2022.942642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382239/
https://www.ncbi.nlm.nih.gov/pubmed/35990692
http://dx.doi.org/10.3389/fimmu.2022.942642

Ejemplares similares